Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Otto

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|May 1, 1984
Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on synthesis of herpes simplex virus type 1-specific polypeptidesS A Siegel, M J Otto, E De Clercq, et al.
Antiviral Chemistry & Chemotherapy|January 6, 1999
The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analoguesS K Ladner, T J Miller, M J Otto, et al.
Journal of Medicinal Chemistry|December 1, 1985
[[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoatingG D Diana, M A McKinlay, M J Otto, et al.
Virology|September 1, 1987
Inhibition of poliovirus uncoating by disoxaril (WIN 51711)H Zeichhardt, M J Otto, M A McKinlay, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 13, 2014
[Eosinophilic otitis media]Monique A M de Jong, L O M J Otto Smithuis, Robert J Stokroos
AIDS (London, England)|June 1, 1994
In vitro susceptibility of clinical isolates of HIV-1 to XM323, a non-peptidyl HIV protease inhibitorD L Winslow, D Mayers, H Scarnati, et al.
AIDS Research and Human Retroviruses|January 1, 1995
Limited sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitorsD L Winslow, S Stack, R King, et al.
Antiviral Research|March 1, 1986
Production of herpes simplex virus type 1 thymidine kinase in the presence of thymidine analoguesM L Zucker, W R Mancini, M J Otto, et al.
Antiviral Research|January 1, 1985
Basic biochemical and pharmacological aspects of antiviral agentsW H Prusoff, M Zucker, W R Mancini, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2000
Phenylpropenamide derivatives as inhibitors of hepatitis B virus replicationR B Perni, S C Conway, S K Ladner, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|May 1, 1984
Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on synthesis of herpes simplex virus type 1-specific polypeptidesS A Siegel, M J Otto, E De Clercq, et al.
Antiviral Chemistry & Chemotherapy|January 6, 1999
The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analoguesS K Ladner, T J Miller, M J Otto, et al.
Journal of Medicinal Chemistry|December 1, 1985
[[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoatingG D Diana, M A McKinlay, M J Otto, et al.
Virology|September 1, 1987
Inhibition of poliovirus uncoating by disoxaril (WIN 51711)H Zeichhardt, M J Otto, M A McKinlay, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 13, 2014
[Eosinophilic otitis media]Monique A M de Jong, L O M J Otto Smithuis, Robert J Stokroos
AIDS (London, England)|June 1, 1994
In vitro susceptibility of clinical isolates of HIV-1 to XM323, a non-peptidyl HIV protease inhibitorD L Winslow, D Mayers, H Scarnati, et al.
AIDS Research and Human Retroviruses|January 1, 1995
Limited sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitorsD L Winslow, S Stack, R King, et al.
Antiviral Research|March 1, 1986
Production of herpes simplex virus type 1 thymidine kinase in the presence of thymidine analoguesM L Zucker, W R Mancini, M J Otto, et al.
Antiviral Research|January 1, 1985
Basic biochemical and pharmacological aspects of antiviral agentsW H Prusoff, M Zucker, W R Mancini, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2000
Phenylpropenamide derivatives as inhibitors of hepatitis B virus replicationR B Perni, S C Conway, S K Ladner, et al.
Pageof 4